What is it about?
The interdisciplinary science of oncology and cardiology is important because many anticancer agents possess toxicity, in addition, the multiple chronic disease states of the patient may also add further risk of cardiovascular toxicity, thus demanding a careful assessment and perioding monitoring for patients on anticancer therapies
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
This review summarizes the key aspects of specific drug therapies in terms of their risk assessment, monitoring, clinical presentations and mitigation strategies
Perspectives
Cardio-oncology is an exciting field; it is emerging to be the next wave of clinical practice for health care professionals.
Dr. Clement Chung
Houston Methodist
Read the Original
This page is a summary of: Rising with cardio-oncology: Clinical considerations of cardiotoxicity with select anticancer drug therapies, American Journal of Health-System Pharmacy, October 2025, Oxford University Press (OUP),
DOI: 10.1093/ajhp/zxaf282.
You can read the full text:
Contributors
The following have contributed to this page
